benefits of glp-1 microdosing Medications There isn't enough data to
Description
R., & Tschp, M
Mateo Montalvo: writing original draft (supporting), writing review and editing (equal)
A systematic translational roadmap will be required to realize their potential in NDDs
Kirchgessner TG, Sleph P, Ostrowski J et al (2016) Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils
It is not intended as medical advice, diagnosis, or treatment
